Clinical Trial Update: Sativex and Behavioral-relapse Prevention Strategy in Cannabis Dependence [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating Sativex for cannabis dependence and a behavioral-relapse prevention strategy; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cannabis Dependence

Drugs mentioned

• Sativex (nabiximol)

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Cannabis Dependence | Phase 2 | Status: COMPLETED | Results posted: 2017-10-02